DE69921137D1 - Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster - Google Patents

Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster

Info

Publication number
DE69921137D1
DE69921137D1 DE1999621137 DE69921137T DE69921137D1 DE 69921137 D1 DE69921137 D1 DE 69921137D1 DE 1999621137 DE1999621137 DE 1999621137 DE 69921137 T DE69921137 T DE 69921137T DE 69921137 D1 DE69921137 D1 DE 69921137D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
compositions containing
antiviral agent
herpes zoster
gaba analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE1999621137
Other languages
English (en)
Other versions
DE69921137T2 (de
Inventor
Leslie Magnus
A Segal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE69921137D1 publication Critical patent/DE69921137D1/de
Publication of DE69921137T2 publication Critical patent/DE69921137T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69921137T 1998-07-09 1999-06-18 Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster Expired - Fee Related DE69921137T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9217198P 1998-07-09 1998-07-09
US92171P 1998-07-09
PCT/US1999/013947 WO2000002592A1 (en) 1998-07-09 1999-06-18 Pharmaceutical composition containinig gaba analogs and an antiviral agent to treat shingles

Publications (2)

Publication Number Publication Date
DE69921137D1 true DE69921137D1 (de) 2004-11-18
DE69921137T2 DE69921137T2 (de) 2006-02-02

Family

ID=22231986

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69921137T Expired - Fee Related DE69921137T2 (de) 1998-07-09 1999-06-18 Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster

Country Status (17)

Country Link
EP (1) EP1093366B1 (de)
JP (1) JP2002520300A (de)
KR (1) KR20010071776A (de)
AT (1) ATE279188T1 (de)
AU (1) AU765246B2 (de)
CA (1) CA2332929C (de)
DE (1) DE69921137T2 (de)
DK (1) DK1093366T3 (de)
ES (1) ES2230863T3 (de)
ID (1) ID27395A (de)
NO (1) NO20010116D0 (de)
NZ (2) NZ508489A (de)
PL (1) PL345337A1 (de)
PT (1) PT1093366E (de)
SI (1) SI1093366T1 (de)
WO (1) WO2000002592A1 (de)
ZA (1) ZA200007169B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541215A (ja) 1999-04-09 2002-12-03 ユーロ−セルティック エス． ア． ナトリウムチャネル遮断薬組成物およびその使用
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
DE60209152T2 (de) 2001-09-03 2006-08-03 Newron Pharmaceuticals S.P.A. Pharmazeutische zusammensetzung, umfassend gabapentin oder ein analogon davon und ein alpha-aminoamid
RS54522B1 (en) 2005-12-22 2016-06-30 Newron Pharmaceuticals S.P.A. 2-Phenylethylamino Derivatives as Modulators of Calcium and (or Sodium) Channels
MX2007006093A (es) * 2007-05-21 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivo y un agente antiviral.
KR20160095358A (ko) 2015-02-03 2016-08-11 고려대학교 산학협력단 우고닌 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 헤르페스 바이러스 감염 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111138A (en) * 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9321394D0 (en) * 1993-10-16 1993-12-08 Smihtkline Beecham P L C Pharmaceuticals
AU731279B2 (en) * 1996-03-14 2001-03-29 Warner-Lambert Company Novel bridged cyclic amino acids as pharmaceutical agents
US6001876A (en) * 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain

Also Published As

Publication number Publication date
DE69921137T2 (de) 2006-02-02
ZA200007169B (en) 2002-03-04
ID27395A (id) 2001-04-05
EP1093366A1 (de) 2001-04-25
PL345337A1 (en) 2001-12-17
CA2332929A1 (en) 2000-01-20
ATE279188T1 (de) 2004-10-15
NZ525623A (en) 2005-08-26
AU4701699A (en) 2000-02-01
PT1093366E (pt) 2005-02-28
CA2332929C (en) 2005-05-31
AU765246B2 (en) 2003-09-11
DK1093366T3 (da) 2004-12-06
NO20010116L (no) 2001-01-08
JP2002520300A (ja) 2002-07-09
NO20010116D0 (no) 2001-01-08
WO2000002592A1 (en) 2000-01-20
NZ508489A (en) 2004-06-25
SI1093366T1 (en) 2005-02-28
EP1093366B1 (de) 2004-10-13
KR20010071776A (ko) 2001-07-31
ES2230863T3 (es) 2005-05-01

Similar Documents

Publication Publication Date Title
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
ATE245650T1 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
DE69722426D1 (de) Isobutylgaba und dessen derivate zur schmerzbehandlung
TR199900308T2 (xx) Tiyenopirimidinler
DK0758895T3 (da) Sublinguale dosisformer indeholdende apomorphin til anvendelse ved behandling af erektil dysfunktion
CA2333024A1 (en) Method for the treatment of insomnia
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
ATE284216T1 (de) Formulierungen und verfahren zur verminderung von hautirritationen
ATE278398T1 (de) Verfahren zur behandlung von viralen infektionen
FR2590805B1 (fr) Procede et installation de neutralisation de fumees acides provenant notamment de la combustion de residus
DE69921137D1 (de) Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster
DE69802113D1 (de) Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen
DK1032378T3 (da) Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
IL132709A0 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
ATE321589T1 (de) Verwendung einer zubereitung und ein kosmetisches verfahren zur verminderung und vorbeugung von beissender der haut
DE60134337D1 (de) N-alkylierte gaba verbindungen, verfahren zu deren
DE59000195D1 (de) Pharmazeutisches praeparat zur behandlung von lebererkrankungen.
DE69838980D1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
DE69629282D1 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern
BR9911950A (pt) Composição farmacêutica contendo análogos gaba e um agente antiviral para tratamento de herpes zoster
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
BR9911943A (pt) Composições compreendendo análogos gaba e um descongestionante para aliviar dor de cabeça de sino
ATE155144T1 (de) Peptidderivate
DE69820511D1 (de) Aminosäurederivate und diese enthaltende Zusammensetzungen zur Hemmung von aktivem Sauerstoff

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee